Pharmacy Benefit Management

From Drug Benefit News - Pharmaceutical manufacturers, covered entities and other stakeholders in the 340B Drug Pricing Program are once again sweating it out as an expected “mega-guidance” spends its third month at the Office of Management and Budget (OMB). Industry insiders say the pending guidance could, among other things, finally place some limits on the wildly expanding contract pharmacy arrangements that may lead to duplicate discounts being paid by manufacturers to 340B entities and commercial and/or Medicaid plans. Read more

From Specialty Pharmacy News - If 10% of Californians who have hepatitis C are treated with newer, more effective yet costly specialty drugs, projected costs over the next 12 months would be $4.77 billion, with $2.05 billion of that spent on the state-funded population. That’s one of the findings of a study conducted by The Taylor Feldman Group for the California Association of Health Plans that was released last month. Read more

Pharmacy Benefit Management Blog

By Lauren Flynn Kelly - August 31, 2015
A couple weeks ago, Kim Kardashian West set off a firestorm of controversy — OK, that might be a slight exaggeration — when her Instagram selfie touting the results of morning sickness pill Diclegis (doxylamine succinate and pyridoxine HCl) failed to properly warn people of the risks associated...
By Lauren Flynn Kelly - August 20, 2015
In a pretty historic move for women’s sexual health, the FDA on Aug. 18 approved Addyi (flibanserin) to treat acquired, generalized hypoactive sexual desire disorder in premenopausal women. Before Addyi, there were no FDA-approved treatments for sexual desire disorders in men or women. That popular...
By Lauren Flynn Kelly - July 27, 2015
As the first of several drugs in a new class of injectable cholesterol-lowering drugs that have the potential to advance both treatment and pharmaceutical costs, Regeneron Pharmaceuticals Inc./Sanofi’s Praluent (alirocumab), which the FDA approved Friday, is arguably the most anticipated drug...

It's quick and easy to sign up for FREE access to!

Why do I need to register?